ArticleBMC surgery2025
Intraoperative predictors of major adverse cardiovascular and cerebrovascular events risk following hepatobiliary and pancreatic surgery: insights from the INSPIRE dataset.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor adverse cardiovascular and cerebrovascular events (MACCE) pose significant challenges in hepatobiliary and pancreatic surgeries, contributing to increased morbidity, mortality, and healthcare burdens. Accurate identification of perioperative risk factors remains critical yet underexplored due to limited large-scale data. This study aimed to find intraoperative predictors of MACCE within 30 (MACCE-30) and 90 days (MACCE-90) post-surgery using the INSPIRE database.
methodsA retrospective cohort of 6135 patients from Seoul National University Hospital was analyzed. MACCE was defined as angina, myocardial infarction, cardiac arrest, arrhythmia, heart failure, stroke, or in-hospital mortality. Variables including patient characteristics, intraoperative factors (e.g., estimated blood loss [EBL], crystalloid volume), and comorbidities were extracted. Univariate Cox proportional hazards models identified variables (p < 0.2) for multivariate analysis, with Kaplan-Meier plots visualizing survival differences.
resultsOf 6135 patients, 179 experienced MACCE-90. Multivariate analysis identified male sex (HR 1.88, 95% CI 1.27-2.78, p < 0.01), EBL (HR 1.19, 95% CI 1.03-1.37, p = 0.02), and crystalloid infusion volume (HR 1.29, 95% CI 1.00-1.65, p = 0.05) as significant predictors of MACCE-90. Mean EBL was 565 mL (MACCE) versus 357 mL (non-MACCE), and crystalloid volume was 498 mL versus 486 mL. We observed no significant difference in early survival based on sex, EBL, or infused crystaollioids.
conclusionMale sex, higher EBL, and crystalloid volumes predict MACCE-90. Optimized management and refined protocols are needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.